BRIEF-Valeant Pharmaceuticals enter amendment, waiver to third amended,restated agreement

Mon Apr 11, 2016 4:42pm EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

April 11 (Reuters) - Valeant Pharmaceuticals International Inc

* Entered into amendment and waiver to third amended,restated credit,guaranty agreement, dated as of feb 13, 2012

* Amendment extends deadline for filing company's form 10-k for fiscal year ended dec. 31, 2015 to may 31, 2016

* Amendment also permits company to incur up to $750 million of additional unsecured indebtedness at any time

* Amendment modifies add-backs to consolidated adjusted ebitda under credit agreement Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)